Oncology & Cancer

Ovarian cancer: Artificial intelligence predicts therapy responses

A model based on artificial intelligence is able to predict the therapy outcome (measured by volumetric reduction of tumor lesions) in 80% of ovarian cancer patients. The AI-based model has an accuracy of 80%, significantly ...

Genetics

New subtypes identified in difficult-to-treat ovarian cancer

Every year, approximately 400 women die of ovarian cancer in Finland, while the corresponding figure for Europe overall is more than 40,000. Ovarian cancer is a genetically very heterogeneous disease, which makes it exceptionally ...

Oncology & Cancer

Study links obesity with dampened immune detection of oral cancers

A team from the University of Michigan Rogel Cancer Center and School of Dentistry, led by Yu Leo Lei, D.D.S., Ph.D., have identified a mechanism in mice for how obesity affects some oral cancers' ability to escape from the ...

Oncology & Cancer

New genetic test can improve ovarian cancer treatment

A genetic test developed in a study at the University of Helsinki and Helsinki University Hospital identifies ovarian cancer patients who benefit from PARP inhibitors, a treatment option.

Oncology & Cancer

Novel T cell receptor therapy shows early anti-tumor activity

Afamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A4 cancer antigen, achieved clinically significant results for patients with multiple solid tumor types ...

page 1 from 14